Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave

被引:0
|
作者
Jessica T. Davis
Matteo Chinazzi
Nicola Perra
Kunpeng Mu
Ana Pastore y Piontti
Marco Ajelli
Natalie E. Dean
Corrado Gioannini
Maria Litvinova
Stefano Merler
Luca Rossi
Kaiyuan Sun
Xinyue Xiong
Ira M. Longini
M. Elizabeth Halloran
Cécile Viboud
Alessandro Vespignani
机构
[1] Northeastern University,Laboratory for the Modeling of Biological and Socio
[2] University of Greenwich,technical Systems
[3] Indiana University School of Public Health,Networks and Urban Systems Centre
[4] Emory University,Department of Epidemiology and Biostatistics
[5] ISI Foundation,Department of Biostatistics and Bioinformatics
[6] Bruno Kessler Foundation,Division of International Epidemiology and Population Studies, Fogarty International Center
[7] National Institutes of Health,Department of Biostatistics, College of Public Health and Health Professions
[8] University of Florida,Department of Biostatistics
[9] Vaccine and Infectious Disease Division,undefined
[10] Fred Hutchinson Cancer Research Center,undefined
[11] University of Washington,undefined
来源
Nature | 2021年 / 600卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Considerable uncertainty surrounds the timeline of introductions and onsets of local transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) globally1–7. Although a limited number of SARS-CoV-2 introductions were reported in January and February 2020 (refs.8,9), the narrowness of the initial testing criteria, combined with a slow growth in testing capacity and porous travel screening10, left many countries vulnerable to unmitigated, cryptic transmission. Here we use a global metapopulation epidemic model to provide a mechanistic understanding of the early dispersal of infections and the temporal windows of the introduction of SARS-CoV-2 and onset of local transmission in Europe and the USA. We find that community transmission of SARS-CoV-2 was likely to have been present in several areas of Europe and the USA by January 2020, and estimate that by early March, only 1 to 4 in 100 SARS-CoV-2 infections were detected by surveillance systems. The modelling results highlight international travel as the key driver of the introduction of SARS-CoV-2, with possible introductions and transmission events as early as December 2019 to January 2020. We find a heterogeneous geographic distribution of cumulative infection attack rates by 4 July 2020, ranging from 0.78% to 15.2% across US states and 0.19% to 13.2% in European countries. Our approach complements phylogenetic analyses and other surveillance approaches and provides insights that can be used to design innovative, model-driven surveillance systems that guide enhanced testing and response strategies.
引用
收藏
页码:127 / 132
页数:5
相关论文
共 50 条
  • [41] SARS-CoV-2/COVID-19-Auswirkungen auf die PlazentaImpact of SARS-CoV-2/COVID-19 on the placenta
    T. Menter
    A. Tzankov
    E. Bruder
    Der Pathologe, 2021, 42 (6): : 591 - 597
  • [42] A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals
    Chavda, Vivek P.
    Feehan, Jack
    Apostolopoulos, Vasso
    VACCINES, 2021, 9 (06)
  • [43] Cryptic transmission of SARS-CoV-2 in Washington state
    Bedford, Trevor
    Greninger, Alexander L.
    Roychoudhury, Pavitra
    Starita, Lea M.
    Famulare, Michael
    Huang, Meei-Li
    Nalla, Arun
    Pepper, Gregory
    Reinhardt, Adam
    Xie, Hong
    Shrestha, Lasata
    Nguyen, Truong N.
    Adler, Amanda
    Brandstetter, Elisabeth
    Cho, Shari
    Giroux, Danielle
    Han, Peter D.
    Fay, Kairsten
    Frazar, Chris D.
    Ilcisin, Misja
    Lacombe, Kirsten
    Lee, Jover
    Kiavand, Anahita
    Richardson, Matthew
    Sibley, Thomas R.
    Truong, Melissa
    Wolf, Caitlin R.
    Nickerson, Deborah A.
    Rieder, Mark J.
    Englund, Janet A.
    Hadfield, James
    Hodcroft, Emma B.
    Huddleston, John
    Moncla, Louise H.
    Mueller, Nicola F.
    Neher, Richard A.
    Deng, Xianding
    Gu, Wei
    Federman, Scot
    Chiu, Charles
    Duchin, Jeffrey S.
    Gautom, Romesh
    Melly, Geoff
    Hiatt, Brian
    Dykema, Philip
    Lindquist, Scott
    Queen, Krista
    Tao, Ying
    Uehara, Anna
    Tong, Suxiang
    SCIENCE, 2020, 370 (6516) : 571 - +
  • [44] SARS-CoV-2 and COVID-19: A Narrative Review
    Blann, A. D.
    Heitmar, R.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2022, 79
  • [45] Perspective: SARS-CoV-2, COVID-19 and Haematologists
    Gale, Robert Peter
    ACTA HAEMATOLOGICA, 2021, 144 (02) : 117 - 120
  • [46] SARS-CoV-2 (COVID-19) and cystic fibrosis
    Stanton, Bruce A.
    Hampton, Thomas H.
    Ashare, Alix
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2020, 319 (03) : L408 - L415
  • [47] Impact of SARS-CoV-2/COVID-19 on the placenta
    Menter, T.
    Tzankov, A.
    Bruder, E.
    PATHOLOGE, 2021, 42 (06): : 591 - 597
  • [48] The evolution of SARS-CoV-2 and the COVID-19 pandemic
    Si, Yuanfang
    Wu, Weidong
    Xue, Xia
    Sun, Xiangdong
    Qin, Yaping
    Li, Ya
    Qiu, Chunjing
    Li, Yingying
    Zhuo, Ziran
    Mi, Yang
    Zheng, Pengyuan
    PEERJ, 2023, 11
  • [49] The evolution of SARS-CoV-2 and the COVID-19 pandemic
    Si, Yuanfang
    Wu, Weidong
    Xue, Xia
    Sun, Xiangdong
    Qin, Yaping
    Li, Ya
    Qiu, Chunjing
    Li, Yingying
    Zhuo, Ziran
    Mi, Yang
    Zheng, Pengyuan
    PEERJ, 2023, 11
  • [50] COVID-19: implications of SARS-CoV-2 in Colombia
    Almeida-Espinosa, Alexander
    Sarmiento-Ardila, Jorge A.
    GACETA MEDICA DE MEXICO, 2020, 156 (04): : 334 - 338